12-2486244-A-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_000719.7(CACNA1C):​c.898A>G​(p.Asn300Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,613,330 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000059 ( 0 hom., cov: 32)
Exomes š‘“: 0.000070 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

2
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.562

Publications

7 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 12-2486244-A-G is Benign according to our data. Variant chr12-2486244-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 457002.
BS2
High AC in GnomAd4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.988A>G p.Asn330Asp missense_variant Exon 6 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.898A>G p.Asn300Asp missense_variant Exon 6 of 46 ENSP00000507309.1
CACNA1CENST00000682152.1 linkc.847A>G p.Asn283Asp missense_variant Exon 5 of 6 ENSP00000506759.1
CACNA1CENST00000480911.6 linkn.898A>G non_coding_transcript_exon_variant Exon 6 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.0000592
AC:
9
AN:
152058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000241
AC:
6
AN:
248554
AF XY:
0.0000445
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000698
AC:
102
AN:
1461272
Hom.:
0
Cov.:
31
AF XY:
0.0000702
AC XY:
51
AN XY:
726910
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33470
American (AMR)
AF:
0.0000671
AC:
3
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86160
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000873
AC:
97
AN:
1111624
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
152058
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41392
American (AMR)
AF:
0.000131
AC:
2
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000464
Hom.:
0
Bravo
AF:
0.0000491
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
Oct 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Apr 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jul 05, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
CardioboostArm
Benign
0.066
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.43
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.091
FATHMM_MKL
Uncertain
0.91
D
M_CAP
Pathogenic
0.65
D
MetaRNN
Uncertain
0.62
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.11
D
MutationAssessor
Benign
-0.63
.;N;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;.;.;.
PhyloP100
0.56
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.7
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Pathogenic
0.77
Sift
Benign
0.47
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.34
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.14, 0.0010, 0.0, 0.066, 0.099, 0.27, 0.21, 0.94, 0.59
.;B;.;B;B;B;B;B;B;B;B;B;B;B;P;B;.;B;B;.;.;.;P
Vest4
0.64
MVP
0.77
MPC
1.2
ClinPred
0.23
T
GERP RS
5.0
gMVP
0.94
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200289321; hg19: chr12-2595410; API